 Katherine Kichula
Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, KIR | 11 | 2025 | 110 | 1.790 |
Why?
| | HLA Antigens | 5 | 2026 | 225 | 0.840 |
Why?
| | Killer Cells, Natural | 8 | 2025 | 469 | 0.810 |
Why?
| | Alleles | 11 | 2026 | 881 | 0.700 |
Why?
| | Genotype | 7 | 2025 | 1835 | 0.450 |
Why?
| | Hematopoietic Stem Cell Transplantation | 3 | 2025 | 676 | 0.430 |
Why?
| | Haplotypes | 6 | 2025 | 490 | 0.410 |
Why?
| | Receptors, KIR2DL1 | 2 | 2024 | 21 | 0.370 |
Why?
| | Polymorphism, Genetic | 2 | 2024 | 612 | 0.340 |
Why?
| | Selection, Genetic | 3 | 2026 | 256 | 0.280 |
Why?
| | HLA-C Antigens | 3 | 2024 | 36 | 0.270 |
Why?
| | Histocompatibility Antigens Class I | 3 | 2024 | 202 | 0.240 |
Why?
| | Adenocarcinoma, Follicular | 1 | 2026 | 41 | 0.240 |
Why?
| | Receptors, KIR3DL1 | 2 | 2024 | 20 | 0.230 |
Why?
| | Major Histocompatibility Complex | 2 | 2024 | 229 | 0.230 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2025 | 19 | 0.230 |
Why?
| | Gene Flow | 1 | 2026 | 85 | 0.230 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2026 | 154 | 0.220 |
Why?
| | Immunogenetics | 1 | 2024 | 7 | 0.210 |
Why?
| | Antigens, Neoplasm | 1 | 2026 | 272 | 0.210 |
Why?
| | Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2024 | 21 | 0.210 |
Why?
| | Virus Activation | 1 | 2024 | 95 | 0.210 |
Why?
| | Cytomegalovirus | 1 | 2024 | 168 | 0.200 |
Why?
| | Genetic Predisposition to Disease | 4 | 2025 | 2365 | 0.200 |
Why?
| | HLA-DP beta-Chains | 1 | 2023 | 87 | 0.190 |
Why?
| | Multimorbidity | 1 | 2023 | 63 | 0.190 |
Why?
| | Transplantation Conditioning | 1 | 2024 | 186 | 0.190 |
Why?
| | Cytomegalovirus Infections | 1 | 2024 | 206 | 0.190 |
Why?
| | T-Lymphocytes | 3 | 2026 | 1982 | 0.180 |
Why?
| | Receptors, KIR3DS1 | 1 | 2022 | 7 | 0.180 |
Why?
| | Thyroid Neoplasms | 1 | 2026 | 346 | 0.180 |
Why?
| | Minority Groups | 1 | 2024 | 282 | 0.180 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2023 | 364 | 0.170 |
Why?
| | Gene Frequency | 3 | 2025 | 481 | 0.140 |
Why?
| | Pre-Eclampsia | 1 | 2020 | 205 | 0.140 |
Why?
| | Primates | 1 | 2019 | 132 | 0.140 |
Why?
| | Heterozygote | 1 | 2019 | 315 | 0.130 |
Why?
| | Genome-Wide Association Study | 1 | 2024 | 1407 | 0.130 |
Why?
| | Transplantation, Homologous | 2 | 2025 | 415 | 0.100 |
Why?
| | China | 2 | 2024 | 269 | 0.100 |
Why?
| | HLA-B Antigens | 2 | 2024 | 57 | 0.100 |
Why?
| | DNA Copy Number Variations | 2 | 2025 | 183 | 0.090 |
Why?
| | Humans | 18 | 2026 | 144957 | 0.090 |
Why?
| | Adult | 7 | 2026 | 40506 | 0.070 |
Why?
| | Middle Aged | 6 | 2026 | 35928 | 0.070 |
Why?
| | Genetic Variation | 2 | 2024 | 984 | 0.070 |
Why?
| | Male | 8 | 2026 | 72406 | 0.060 |
Why?
| | Papua New Guinea | 1 | 2026 | 10 | 0.060 |
Why?
| | Thyroglobulin | 1 | 2026 | 29 | 0.060 |
Why?
| | Female | 8 | 2026 | 78376 | 0.060 |
Why?
| | Norway | 1 | 2025 | 45 | 0.060 |
Why?
| | Signal Transduction | 1 | 2019 | 5233 | 0.060 |
Why?
| | Oceania | 1 | 2024 | 5 | 0.050 |
Why?
| | HLA-A24 Antigen | 1 | 2024 | 5 | 0.050 |
Why?
| | Genetics, Population | 1 | 2026 | 215 | 0.050 |
Why?
| | Histocompatibility Testing | 1 | 2024 | 121 | 0.050 |
Why?
| | Egypt | 1 | 2023 | 13 | 0.050 |
Why?
| | Australia | 1 | 2024 | 286 | 0.050 |
Why?
| | Lymphocyte Depletion | 1 | 2024 | 132 | 0.050 |
Why?
| | Young Adult | 3 | 2025 | 14126 | 0.050 |
Why?
| | Granzymes | 1 | 2023 | 49 | 0.050 |
Why?
| | Graft vs Host Disease | 1 | 2025 | 264 | 0.050 |
Why?
| | Malaysia | 1 | 2020 | 16 | 0.040 |
Why?
| | Aged | 3 | 2026 | 25947 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2024 | 668 | 0.040 |
Why?
| | Tissue Donors | 1 | 2024 | 424 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2025 | 11695 | 0.040 |
Why?
| | Phylogeography | 1 | 2019 | 55 | 0.040 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2026 | 2147 | 0.030 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2019 | 148 | 0.030 |
Why?
| | Hominidae | 1 | 2019 | 87 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 570 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2020 | 550 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2021 | 1126 | 0.030 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2024 | 683 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2024 | 3608 | 0.030 |
Why?
| | Prognosis | 1 | 2025 | 4293 | 0.030 |
Why?
| | Autoantibodies | 1 | 2023 | 1504 | 0.030 |
Why?
| | Protein Conformation | 1 | 2019 | 946 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2019 | 2157 | 0.030 |
Why?
| | Biological Evolution | 1 | 2019 | 488 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2883 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1619 | 0.020 |
Why?
| | Protein Binding | 1 | 2019 | 2276 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5872 | 0.020 |
Why?
| | Pregnancy | 1 | 2020 | 7191 | 0.020 |
Why?
| | Adolescent | 1 | 2025 | 22453 | 0.010 |
Why?
| | Animals | 1 | 2019 | 38109 | 0.010 |
Why?
|
|
Kichula's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|